Sanofi Free Cash Flow 2010-2024 | SNY

Sanofi free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.

  • Sanofi annual free cash flow for 2023 was $8.928B, a 13.65% decline from 2022.
  • Sanofi annual free cash flow for 2022 was $10.339B, a 4.98% decline from 2021.
  • Sanofi annual free cash flow for 2021 was $10.881B, a 52.33% increase from 2020.

Sanofi Free Cash Flow 2010-2024 | SNY

  • Sanofi annual free cash flow for 2023 was $8.928B, a 13.65% decline from 2022.
  • Sanofi annual free cash flow for 2022 was $10.339B, a 4.98% decline from 2021.
  • Sanofi annual free cash flow for 2021 was $10.881B, a 52.33% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$755.3B
Novo Nordisk (NVO)$392.1B
Johnson & Johnson (JNJ)$351.2B
AbbVie (ABBV)$318.1B
Merck (MRK)$251.6B
AstraZeneca (AZN)$205.6B
Novartis AG (NVS)$201B
Pfizer (PFE)$151.5B
Bayer (BAYRY)$19.1B
Innoviva (INVA)$1.1B